|
|
Volumn 127, Issue 1, 2001, Pages 113-120
|
|
Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FOLINIC ACID;
IMMUNOGLOBULIN G;
PYRIMETHAMINE;
SPIRAMYCIN;
SULFADIAZINE;
ADULT;
AGE;
ARTICLE;
AUSTRIA;
CHILD;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
COMPARATIVE STUDY;
CONGENITAL TOXOPLASMOSIS;
CONTROLLED STUDY;
DENMARK;
DISEASE TRANSMISSION;
ECHOGRAPHY;
ECOLOGY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW UP;
FRANCE;
HUMAN;
IMMUNOFLUORESCENCE TEST;
INFANT;
MAJOR CLINICAL STUDY;
NETHERLANDS;
OPHTHALMOSCOPY;
POLYMERASE CHAIN REACTION;
PRENATAL CARE;
RISK ASSESSMENT;
SEROCONVERSION;
SHORT COURSE THERAPY;
TOXOPLASMA GONDII;
TOXOPLASMOSIS;
ANTI-BACTERIAL AGENTS;
AUSTRIA;
DENMARK;
DISEASE TRANSMISSION, VERTICAL;
ECOLOGY;
FEMALE;
FRANCE;
GESTATIONAL AGE;
HUMANS;
INFANT, NEWBORN;
NETHERLANDS;
PREGNANCY;
PRENATAL CARE;
RISK;
SPIRAMYCIN;
TOXOPLASMOSIS, CONGENITAL;
|
|
EID: 17944382231
PISSN: 09502688
EISSN: None
Source Type: Journal
DOI: 10.1017/S095026880100560X Document Type: Article |
|
Times cited : (64)
|
|
References (29)
|
